ATG16L1 and Cowden disease: Further studies found that ATG16L1 has an important regulatory role in modulating the pro-inflammatory functions of activated NOD2 and that, in the context of CD-associated ATG16L1 variants, stimulation of NOD2 with bacteria-derived ligands promotes a NOD2-mediated pathologic inflammatory response [57,58].